Swedish Drugmaker Meda Spurns $24B Mylan Merger Pitch
Swedish drugmaker Meda AB said Friday that it spurned a merger proposal from Mylan Inc. that would have united the companies as a $24 billion pharmaceuticals powerhouse, and suggested it would...To view the full article, register now.
Already a subscriber? Click here to view full article